Answers are grounded in this paper and cite their sources.
Squamous cell carcinoma (SCC) of the head presents a significant challenge in achieving complete surgical excision while preserving function and aesthetics. Neoadjuvant intralesional methotrexate (MTX) has emerged as a potential strategy to reduce tumour burden preoperatively, facilitating more conservative surgical excisions. The results demonstrated significant lesion shrinkage, with a mean tumour size reduction of 68%, enabling less invasive surgical interventions.
No takes yet. Share an insight, caveat, or question.
Giorgio et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: